These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2701905)

  • 1. The presentation of antigen by MHC class II molecules.
    Adorini L
    Year Immunol; 1989-1990; 6():21-37. PubMed ID: 2701905
    [No Abstract]   [Full Text] [Related]  

  • 2. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
    Dang LH; Lien LL; Benacerraf B; Rock KL
    J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mhc-guided processing: binding of large antigen fragments.
    Sercarz EE; Maverakis E
    Nat Rev Immunol; 2003 Aug; 3(8):621-9. PubMed ID: 12974477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen processing and presentation. The biologic role of MHC molecules in determinant selection.
    Benacerraf B
    J Immunol; 1988 Oct; 141(7 Suppl):S17-20. PubMed ID: 2459216
    [No Abstract]   [Full Text] [Related]  

  • 6. Fc receptors for IgG and antigen presentation on MHC class I and class II molecules.
    Amigorena S; Bonnerot C
    Semin Immunol; 1999 Dec; 11(6):385-90. PubMed ID: 10625592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC class II-mediated antigen presentation by alloreactive rat CD4+ T cells does not induce regulatory properties.
    Otto C; Heeg A; Kottenmeier S; Tiurbe GC; Thiede A; Ulrichs K
    Transplant Proc; 2006 Apr; 38(3):755-6. PubMed ID: 16647463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes.
    Herkel J; Jagemann B; Wiegard C; Lazaro JF; Lueth S; Kanzler S; Blessing M; Schmitt E; Lohse AW
    Hepatology; 2003 May; 37(5):1079-85. PubMed ID: 12717388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of major histocompatibility complex molecules in rodent retina. Immunohistochemical study.
    Zhang J; Wu GS; Ishimoto S; Pararajasegaram G; Rao NA
    Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1848-57. PubMed ID: 9286275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentation of antigen and MHC-restricted unresponsiveness.
    Ríhová B
    Folia Biol (Praha); 1995; 41(3-4):140-62. PubMed ID: 7589711
    [No Abstract]   [Full Text] [Related]  

  • 11. Antigen presenting cells and mechanisms of antigen presentation.
    Chesnut RW; Grey HM
    Crit Rev Immunol; 1985; 5(3):263-316. PubMed ID: 3884274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow-derived dendritic cells can process bacteria for MHC-I and MHC-II presentation to T cells.
    Svensson M; Stockinger B; Wick MJ
    J Immunol; 1997 May; 158(9):4229-36. PubMed ID: 9126984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men.
    Holling TM; Schooten E; van Den Elsen PJ
    Hum Immunol; 2004 Apr; 65(4):282-90. PubMed ID: 15120183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invariant chain expression similarly controls presentation of endogenously synthesized and exogenous antigens by MHC class II molecules.
    Lombard-Platet S; Bertolino P; Gimenez C; Humbert M; Gerlier D; Rabourdin-Combe C
    Cell Immunol; 1993 Apr; 148(1):60-70. PubMed ID: 8495491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MHC class II-mediated T cell response to DNA.
    Waisman A; Zisman E; Mozes E
    Cell Immunol; 1996 Oct; 173(1):7-14. PubMed ID: 8871596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunogenic potential of human fetal retinal pigment epithelium and its relation to transplantation.
    Rezai KA; Semnani RT; Patel SC; Ernest JT; van Seventer GA
    Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2662-71. PubMed ID: 9375586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-presentation in viral immunity and self-tolerance.
    Heath WR; Carbone FR
    Nat Rev Immunol; 2001 Nov; 1(2):126-34. PubMed ID: 11905820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules.
    Watts C
    Nat Immunol; 2004 Jul; 5(7):685-92. PubMed ID: 15224094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of MHC II and CD1 antigen presentation: from ubiquity to security.
    Gelin C; Sloma I; Charron D; Mooney N
    J Leukoc Biol; 2009 Feb; 85(2):215-24. PubMed ID: 18809734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of naturally processed peptides bound by class II molecules and peptides presented by normal and mutant antigen-presenting cells.
    Sette A; DeMars R; Grey HM; Oseroff C; Southwood S; Appella E; Kubo RT; Hunt DF
    Chem Immunol; 1993; 57():152-65. PubMed ID: 8260087
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.